Takeda Drops Some Infringement Claims In Dexilant Suit

Law360, New York (November 16, 2012, 7:27 PM EST) -- Takeda Pharmaceutical Co. Ltd. has determined that a generic rival's pursuit of a competing version of the Dexilant acid reflux treatment does not infringe a handful of its patents, according to a California federal court's Friday filing entering judgment for the generic drugmaker for four of Takeda's six asserted patents.

U.S. District Judge Joseph C. Spero signed off on a consent decree partially letting off the hook TWi Pharmaceuticals Inc., which Takeda has alleged is attempting to co-opt its patent holdings in its attempt to market...
To view the full article, register now.